Foreword: Dietary Supplement Regulation in Flux
Barbara A. Noah
Western New England University School of Law
January 12, 2012
American Journal of Law and Medicine, Vol. 31, p. 147, 2005
Dietary supplements -- vitamins, minerals, herbs, amino acids, and sundry other substances -- have soared in popularity over the past decade, resulting in a $20 billion industry with over 1,000 manufacturers marketing 29,000 products. These products present vexing regulatory challenges for the Food and Drug Administration (FDA), and, for many years, the agency struggled to formulate an effective regulatory approach. In 1993, the FDA published a notice that summarized its safety concerns associated with various categories of dietary supplements and delineated the rather aggressive regulatory recommendations of an agency task force. Congress quickly reacted to these proposed regulatory initiatives. In 1994, it enacted the Dietary Supplement Health and Education Act (DSHEA), which sharply limits the FDA's express authority to regulate covered products. Purporting to balance concerns about the safety of supplements and consumer freedom to purchase them, DSHEA's highly deregulatory approach won effusive praise from commentators who profess strong faith in the ability of consumers to make intelligent choices about supplement use. Other observers remain dubious, however, that the typical consumer will exercise informed skepticism when it comes to claims about the safety and utility of these products.
Keywords: dietary supplements, regulation, food and drug lawAccepted Paper Series
Date posted: January 12, 2012
© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo8 in 0.453 seconds